Thomas Jefferson University Concussions Nuclear Imaging SPECT

January 29, 2014 — Researchers are seeking to understand what happens inside the living brain after a concussion.  In a study published today in PLOS ONE, researchers at Thomas Jefferson University used single photon emission computed tomography (S.P.E.C.T.) to evaluate two ways to measure physiological brain activity in Traumatic Brain Injury (T.B.I.) patients with chronic, mild symptoms. The findings of their blinded, case-control study are published in an article entitled, Clinical Comparison of 99mTc Exametazime and 123I Ioflupane SPECT in Patients with Chronic Mild Traumatic Brain Injury. The study included 25 cases and 10 controls.
 
The researchers used S.P.E.C.T. to track cerebral blood flow (C.B.F.), movement of blood through the brain and neurotransmitter dopamine by tracking the binding of a dopamine transporter (D.A.T.) tracer.
 
T.B.I. patients were discovered to have an average of six brain regions with abnormal perfusion, while controls had an average of two abnormal regions (P<0.0001).  Patients with headaches had lower C.B.F. in the right frontal lobe and higher C.B.F. in the left parietal lobe compared to patients without headaches. Lower C.B.F. in the right temporal lobe correlated with poorer reported physical health. Higher D.A.T. binding was associated with more depressive symptoms and overall poorer reported mental health.  However, there was no clear association between C.B.F. and D.A.T. binding in the patients studied.
 
Researchers concluded that S.P.E.C.T. imaging of D.A.T. and C.B.F. were useful tools that provide distinct information about brain physiology after T.B.I.
 
For more information: www.jefferson.edu

Related Content

News | Radiopharmaceuticals and Tracers

April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...

Time April 05, 2024
arrow
News | Molecular Imaging

March 29, 2024 — Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated ...

Time March 29, 2024
arrow
News | Radiopharmaceuticals and Tracers

February 21, 2024 — Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next ...

Time February 21, 2024
arrow
News | SPECT Imaging

February 15, 2024 — According to a release issued by the U.S. Food and Drug Administration (FDA), Philips is recalling ...

Time February 15, 2024
arrow
News | Radiopharmaceuticals and Tracers

February 14, 2024 — PanTera, the Belgian joint venture created by IBA and SCK CEN to secure large-scale production of ...

Time February 14, 2024
arrow
News | Quality Assurance (QA)

February 12, 2024 — IBA, a world leader in particle accelerator technology and a world-leading provider of dosimetry and ...

Time February 12, 2024
arrow
News | PET Imaging

February 9, 2024 — A novel PET imaging technique can noninvasively detect active inflammation in the body before ...

Time February 09, 2024
arrow
News | Interventional Radiology

February 6, 2024 — RenovoRx, Inc., a clinical-stage biopharmaceutical company developing novel precision oncology ...

Time February 06, 2024
arrow
News | SNMMI

February 6, 2024 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) held its 2024 SNMMI Mid-Winter Meeting ...

Time February 06, 2024
arrow
Subscribe Now